Growth promoting and metabolic activity of the human insulin analogue [GlyA21,ArgB31,ArgB32]insulin (HOE 901) in muscle cells (Q41128080)

27 September 2017

Growth promoting and metabolic activity of the human insulin analogue [GlyA21,ArgB31,ArgB32]insulin (HOE 901) in muscle cells (English)

1 reference

27 September 2017

Bähr M

1

1 reference

27 September 2017

Kolter T

series ordinal

2

1 reference

27 September 2017

Seipke G

series ordinal

3

1 reference

27 September 2017

Eckel J

series ordinal

4

1 reference

27 September 2017

language of work or name

English

0 references

publication date

1 February 1997

1 reference

European Journal of Pharmacology

27 September 2017

1 reference

27 September 2017

320

1 reference

27 September 2017

2-3

1 reference

27 September 2017

259-265

1 reference

Binding and biological effects of insulin, insulin analogues and insulin-like growth factors in rat aortic smooth muscle cells. Comparison of maximal growth promoting activities

27 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900903-X

Monomeric insulins obtained by protein engineering and their medical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900903-X

Muscle cell differentiation is associated with increased insulin receptor biosynthesis and messenger RNA levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900903-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900903-X

Receptor Binding and Tyrosine Kinase Activation by Insulin Analogues With Extreme Affinities Studied in Human Hepatoma HepG2 Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900903-X

Insulin action on the glucose transport system in isolated cardiocytes from adult rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900903-X

G-protein-mediated regulation of the insulin-responsive glucose transporter in isolated cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900903-X

New directions in drug development: mixtures, analogues, and modeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900903-X

Improving insulin therapy: achievements and challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900903-X

[Lys(B28), Pro(B29)]-human insulin. A rapidly absorbed analogue of human insulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900903-X

NovoSol Basal: pharmacokinetics of a novel soluble long acting insulin analogue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900903-X

Properties of a clonal muscle cell line from rat heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900903-X

The ligand specificities of the insulin receptor and the insulin-like growth factor I receptor reside in different regions of a common binding site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900903-X

Contraction-induced translocation of the glucose transporter Glut4 in isolated ventricular cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900903-X

Intravenous infusion of diarginylinsulin, an insulin analogue: effects on glucose turnover and lipid levels in insulin-treated type II diabetic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900903-X

Insulin dependence of murine lymphoid T-cell leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900903-X

Receptor-binding region of insulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900903-X

Equivalent in vivo biological activity of insulin analogues and human insulin despite different in vitro potencies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900903-X

Metabolic effects of monomeric insulin analogues of different receptor affinity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900903-X

Insulin action on cardiac glucose transport: studies on the role of protein kinase C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900903-X

Insulin and atheroma. 20-yr perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900903-X

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900903-X

In vitro and in vivo potency of insulin analogues designed for clinical use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900903-X

In vitro activity of biosynthetic human diarginylinsulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900903-X

10.1016/S0014-2999(96)00903-X

7 January 2021

Identifiers

DOI

1 reference

27 September 2017

1 reference